A PSMA-targeted US method could be used for detecting PCa lesions and for biopsy guidance, offering a way to improve existing non-contrast enhanced US techniques, while also providing an alternative to more costly and time consuming MRI-based biopsy guidance methods [33]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.